Literature DB >> 4248502

Tetrabenazine for Huntington's chorea.

C A Soutar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4248502      PMCID： PMC1820569          DOI： 10.1136/bmj.4.5726.55

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

Review 2.  VMAT2 Inhibitors in Neuropsychiatric Disorders.

Authors:  Arjun Tarakad; Joohi Jimenez-Shahed
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 3.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

4.  Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease.

Authors:  Mahesh Kandasamy; Ralf Reilmann; Jürgen Winkler; Ulrich Bogdahn; Ludwig Aigner
Journal:  Neurol Res Int       Date:  2011-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.